Gallagher Cam

President, Interim CFO | President | Director

2 companies

Excellent

Trades Analyzed

12M Win Rate

94.9%

Avg 3M Return

+12.7%

Avg 12M Return

+48.2%

Gallagher Cam is a President, Interim CFO at IRD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 29 sells.

Estimated insider holdings value: $12.8M based on current market prices.

Holdings by Company

IRDJan 6, 2026

Current Shares1.99M

Value$10.09M

Net Activity+172.9K

Bought: 172.9KSold: 0

ZNTLMay 31, 2024

Current Shares633.7K

Value$2.72M

Net Activity-515,936

Bought: 0Sold: 515.9K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 8, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	President	Sell	24,874	$23.62	$587,402.98	-2.1%	-6.4%	-57.6%
Oct 17, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	President	Sell	12,500	$23.51	$293,878.75	-3.0%	+2.6%	-21.0%
Oct 6, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	President	Sell	22,500	$22.45	$505,186.46	-1.7%	-6.0%	-10.4%
Sep 16, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	President	Sell	22,500	$24.90	$560,253.68	-1.2%	-18.8%	-1.9%
Apr 5, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$50.48	$504,768.68	-0.7%	-37.7%	-64.3%
Mar 15, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$41.92	$419,241.28	-0.9%	-50.0%	-57.3%
Mar 7, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$44.94	$449,387.24	-1.3%	-41.6%	-58.5%
Feb 15, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$51.93	$519,294.68	-0.9%	-53.7%	-61.3%
Feb 14, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	7,188	$50.19	$360,774.92	-0.6%	-51.2%	-59.9%
Feb 7, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$53.45	$534,473.92	-0.8%	-63.9%	-60.6%